In the last week, the Indian market has stayed flat, yet it is up 44% over the past year with earnings expected to grow by 17% per annum in the next few years. In this dynamic environment, identifying ...

Over the last 7 days, the Indian market has remained flat, with notable gains of 3.5% in the Utilities sector. Despite this ...

In the last week, the Indian market has stayed flat, but it is up 44% over the past year with earnings forecast to grow by 17 ...

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...

UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, ...

US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five ...

Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord ...

Sumeet Bagadia recommends five shares to buy today — Marksans Pharma, Concord Biotech, Magadh Sugar, Prism Johnson, and ...

Marksans Pharma, Concord Biotech Ltd., Interarch Building and Themis Medicare, hit their fresh 52-week highs during the day.

UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and ...

On September 20, Vanguard Group bought shares worth around Rs 1000 crore in seven Indian listed companies via a bulk deal.

Over the past 7 days, the Indian market has risen 1.8%, and over the past 12 months, it is up an impressive 41%. In this ...